0
Abstract: Poster Presentations |

STATIN USE MAY REDUCE THE OCCURRENCE OF VENOUS THROMBOEMBOLISM: A STUDY IN PATIENTS WITH ATHEROSCLEROTIC DISEASE FREE TO VIEW

Danai Khemasuwan, MD*; Young K. Chae, MD; Stafan V. Neagu, MD; Shrika Gupta, MD; Alejandra Carpio, MD; Jorge Mora, MD
Author and Funding Information

Albert Einstein Medical Center, Philadelphia, PA


Chest


Chest. 2009;136(4_MeetingAbstracts):147S. doi:10.1378/chest.136.4_MeetingAbstracts.147S
Text Size: A A A
Published online

Abstract

PURPOSE:  Atherosclerosis and venous thromboembolism (VTE) may share common pathophysiology based on common inflammatory mediators. Statins therapy showed substantial benefit in atherosclerosis, but the effect of statins in venous thromboembolism is still controversial. The objective of this study is to investigate the association between the use of statins in patients with history of atherosclerosis on the occurrence of VTE.

METHODS:  We conducted a retrospective, case-control study, reviewing 593 patients admitted to Albert Einstein Medical Center (AEMC), Philadelphia with a diagnosis of either myocardial infarction or ischemic stroke. Patients who had been treated with anticoagulation therapy before the first visit at AEMC were excluded. The occurrence of VTE, risk factors for VTE, and use of statins were recorded. The patients who either used statins for less than 2 months or never used statins were allocated to the nonuser group.

RESULTS:  The mean age of the entire study population was 67.8 years. 52% of the patients were female and 77% were African American. The overall incidence of VTE was 13%; and 73% (N = 433) were on statins. Among patients on statins, 8.3 % (36/433) developed a VTE, compared to 26.3% (42/160) in the nonuser group [OR (Odd ratio), 0.25; 95% CI, 0.16 –0.42; P < 0.001]. Even after controlling for factors related to VTE (smoking, history of cancer, and immobilization), statins use was still associated with low risk of developing VTE [OR, 0.27; 95% CI, 0.16–0.44; P < 0.001]. Furthermore, high dose statins use (greater than 40 mg/day) [OR, 0.32; 95% CI, 0.12 –0.82; P = 0.017] showed lower occurrence of VTE compared to standard dose statins [OR, 0.48; 95% CI, 0.29–0.78; P = 0.003].

CONCLUSION:  In this study, the use of statins appears to be associated with a significant reduction in the occurrence of VTE with a dose-related response. This possible protective effect of statins warrants further investigation.

CLINICAL IMPLICATIONS:  The use of statins may help to prevent venous thromboembolism in patients with atherosclerotic diseases.

DISCLOSURE:  Danai Khemasuwan, No Financial Disclosure Information; No Product/Research Disclosure Information

Wednesday, November 4, 2009

12:45 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Guidelines
Perioperative protocol. Health care protocol.
Institute for Clinical Systems Improvement
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543